An evaluation of a brief assessment-led intervention with young non-injecting drug users
| ISRCTN | ISRCTN43192662 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN43192662 |
| Protocol serial number | V#1, 10/01/06 |
| Sponsor | King's College London (UK) |
| Funder | Department of Health of England & Wales, Drug Misuse Research Initiative (Phase 2) (UK) |
- Submission date
- 13/02/2008
- Registration date
- 26/02/2008
- Last edited
- 06/08/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Institute of Psychiatry
King's College London
PO Box 048
4 Windsor Walk
London
SE5 8AF
United Kingdom
| J.Marsden@iop.kcl.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | An evaluation of a brief assessment-led intervention with young non-injecting drug users |
| Study objectives | That participants receiving a brief assessment-led intervention would at 3 months follow-up have a lower mean frequency of cannabis use, cocaine use, crack cocaine use and MDMA (3,4 methylenedioxymethamphetamine; Ecstasy) use combined than delayed assessment control participants |
| Ethics approval(s) | King's College London, 17/10/2005, ref: 05/Q0706/219 |
| Health condition(s) or problem(s) studied | Substance misuse |
| Intervention | Experimental: A brief assessment-led intervention a. Drugs and Lifestyle Assessment b. Manual guided 30 minute feedback interview Control 1: Assessment only Control 2: Delayed assessment |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
Combined frequency of cocaine powder use, crack cocaine use, MDMA use and cannabis use, assessed at baseline and 90 days |
| Key secondary outcome measure(s) |
The following were assessed at baseline and 90 days: |
| Completion date | 29/01/2008 |
Eligibility
| Participant type(s) | Other |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 255 |
| Total final enrolment | 342 |
| Key inclusion criteria | 1. 16 to 28 years old 2. Using either cannabis, cocaine powder, crack cocaine, or MDMA on four days in previous month 3. Able speak and comprehend English 4. Written consent |
| Key exclusion criteria | 1. In contact with a drug/alcohol treatment agency in previous 12 months 2. Used opiates more than 30 days in the previous 90 days or in the previous 48 hours before interview 3. Injected more than once in the last 12 months and no more than ten times lifetime 4. Receiving specialist treatment for a mental health problem 5. Participated in a similar research study in the previous 12 months |
| Date of first enrolment | 01/10/2005 |
| Date of final enrolment | 29/01/2008 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
SE5 8AF
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/07/2006 | 06/08/2020 | Yes | No |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
06/08/2020: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.
08/06/2017: No publications found, verifying study status with principal investigator.
